We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 687

Default judgment awarded in respect of infringement of registered trade-mark
  • Borden Ladner Gervais LLP
  • Canada
  • April 30 2014

Teavana Corporation v. Teayama Inc., 2014 FC 372 The Plaintiff commenced an action for trade-mark infringement, passing off and depreciation of


Oder of prohibition issues no promise to treatment in humans or reduced side effects was found
  • Borden Ladner Gervais LLP
  • Canada
  • April 30 2014

Pfizer’s Canadian Patent No. 2,177,576 for Celebrex has withstood Apotex’s allegations and was found to be valid; therefore the Minister is


Carbon Trust found to be confusing with Pacific Carbon Trust
  • Borden Ladner Gervais LLP
  • Canada
  • September 30 2013

Carbon Trust has unsuccessfully appealed a decision of the Trade-marks Opposition Board that refused to register its proposed “‘working with the


Court of Appeal upholds decision awarding Section 8 compensation where sales related to “unauthorized indications” Sanofi-Aventis Canada Inc. v. Teva Canada limited, 2014 FCA 69
  • Borden Ladner Gervais LLP
  • Canada
  • March 24 2014

Drug: ramipril This was an appeal by Sanofi-Aventis Canada Inc. and Sanofi-Aventis Deutschland GmbH (collectively "Sanofi") from a judgment of the


Question remitted to the court a second time for redetermination
  • Borden Ladner Gervais LLP
  • Canada
  • October 25 2012

The Court of Appeal remitted a case to the Court, requiring the Court to redetermine whether Corlac had infringed a method claim by inducement


Double patenting exists notwithstanding changes to NOC Regulations
  • Borden Ladner Gervais LLP
  • Canada
  • September 17 2012

This decision relates to a refusal by the Examiner to issue a patent on the basis of obviousness double patenting


Leave for appeal dismissed with costs
  • Borden Ladner Gervais LLP
  • Canada
  • December 4 2012

The Supreme Court of Canada dismissed Wyeth’s application for leave to appeal the decision of the Federal Court of Appeal which permitted ratiopharm’s s. 8 proceeding, claiming damages from Wyeth, to continue after it amalgamated with Teva


Court of Appeal considers comity as it applies to NOC proceedings
  • Borden Ladner Gervais LLP
  • Canada
  • December 4 2012

Apotex v


Decision refusing to strike second statement of claim upheld on appeal
  • Borden Ladner Gervais LLP
  • Canada
  • December 4 2012

Bertelsen commenced an action for patent infringement by statement of claim (the ''first action''


Court assesses statutory damages for breach of copyright in language proficiency tests
  • Borden Ladner Gervais LLP
  • Canada
  • April 30 2014

This was an uncontested assessment of damages for breach of copyright. The Plaintiff obtained summary judgment (decision here) and the Court directed